Jotin Marango - Aug 19, 2021 Form 4 Insider Report for Aptose Biosciences Inc. (APTO)

Role
Senior VP, CFO, and CBO
Signature
/s/ Janet Clennett as attorney-in-fact for Jotin Marango
Stock symbol
APTO
Transactions as of
Aug 19, 2021
Transactions value $
$0
Form type
4
Date filed
8/23/2021, 04:57 PM
Next filing
Jan 20, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APTO Performance Stock Option Award $0 +200K $0.00 200K Aug 19, 2021 Common Shares 200K $2.35 Direct F1, F2
transaction APTO Performance Stock Option Award $0 +200K $0.00 200K Aug 19, 2021 Common Shares 200K $2.35 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were granted on August 19, 2021 and vest upon the earlier of (i) certain performance conditions or (ii) August 19, 2025, subject to Reporting Person's continued employment with the Issuer.
F2 Options vest in tranches connected with financing events.
F3 Options vest in connection with licensing and partnering events.